Angiotensin receptor antagonists: focus on losartan

Lancet. 1995 Nov 25;346(8987):1403-7. doi: 10.1016/s0140-6736(95)92411-6.
No abstract available

Publication types

  • Review

MeSH terms

  • Angiotensin Receptor Antagonists*
  • Angiotensin-Converting Enzyme Inhibitors / pharmacokinetics
  • Angiotensin-Converting Enzyme Inhibitors / pharmacology
  • Antihypertensive Agents* / pharmacokinetics
  • Antihypertensive Agents* / pharmacology
  • Biphenyl Compounds* / pharmacokinetics
  • Biphenyl Compounds* / pharmacology
  • Clinical Trials as Topic
  • Hemodynamics / drug effects
  • Humans
  • Hypertension / drug therapy
  • Imidazoles* / pharmacokinetics
  • Imidazoles* / pharmacology
  • Kidney / drug effects
  • Losartan
  • Tetrazoles* / pharmacokinetics
  • Tetrazoles* / pharmacology

Substances

  • Angiotensin Receptor Antagonists
  • Angiotensin-Converting Enzyme Inhibitors
  • Antihypertensive Agents
  • Biphenyl Compounds
  • Imidazoles
  • Tetrazoles
  • Losartan